Detalhe da pesquisa
1.
Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1.
Nat Immunol
; 20(12): 1631-1643, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740799
2.
Jets from MRC 0600-399 bent by magnetic fields in the cluster Abell 3376.
Nature
; 593(7857): 47-50, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953411
3.
Novel susceptibility loci for steroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.
Hum Mol Genet
; 31(7): 1082-1095, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850884
4.
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years.
Ann Rheum Dis
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782549
5.
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study.
Ann Rheum Dis
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423757
6.
Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis.
Rheumatology (Oxford)
; 2024 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38851883
7.
Tocilizumab discontinuation after remission achievement in patients with adult-onset Still's disease.
Rheumatology (Oxford)
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507702
8.
Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis.
Rheumatology (Oxford)
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530780
9.
Efficacy Of Baricitinib in Patients With Moderate-To-Severe Rheumatoid Arthritis Up to 6.5 Years Of Treatment: Results Of A Long-Term Study.
Rheumatology (Oxford)
; 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258434
10.
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients.
Rheumatology (Oxford)
; 63(3): 725-733, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289506
11.
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring.
Rheumatology (Oxford)
; 63(2): 525-533, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208196
12.
Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
Cytokine
; 176: 156534, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354516
13.
Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study.
J Rheumatol
; 51(6): 613-621, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359944
14.
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State In Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.
J Rheumatol
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490668
15.
Post hoc analysis of patients with rheumatoid arthritis under clinical remission in two Japanese Phase 3 trials of peficitinib treatment (RAJ3 and RAJ4).
Mod Rheumatol
; 34(3): 453-465, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319017
16.
Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan.
Mod Rheumatol
; 34(3): 576-583, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338284
17.
Relationship between lymphocyte count and risk of infection in Japanese rheumatoid arthritis patients treated with tofacitinib.
Mod Rheumatol
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38801704
18.
Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance.
Mod Rheumatol
; 34(2): 272-286, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405710
19.
Irreversible covalent Bruton's tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate: a randomised, double-blind, phase IIa trial.
Ann Rheum Dis
; 82(8): 1025-1034, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217273
20.
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 81-94, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410794